Additional information
| Use in sports | Not typically used in sports |
|---|---|
| Substance class | Antiprotozoal, irreversible inhibitor of ornithine decarboxylase |
| Side effects | Stinging skin, rash, redness, burning, acneiform eruptions |
| Effects | Reduces rate of hair growth, treats protozoal infections |
| Dosage (sports) | Not applicable |
| Dosage (medical) | For hirsutism, apply a thin layer of 13.9% cream to affected areas twice daily, for sleeping sickness, 400 mg intravenously every 6 hours for 14 days |
| Half-life | 8 hours |
| Main action | Inhibits hair growth and treats African trypanosomiasis (sleeping sickness) |
| Formula | C6H12F2N2O2В·HCl |
| Water Retention | No known water retention effects |
| Chemical name | (RS)-2,5-Diamino-2-(difluoromethyl)pentanoic acid hydrochloride |
| Storage conditions | Store at room temperature away from light and moisture |
| Trade name | Vaniqa, Ornidyl |
| Blood pressure | No significant effects |
| Also known as | DFMO, difluoromethylornithine |
| Lab Test | Not typically required for monitoring |
| Hepatotoxicity | Low risk |
| Manufacturer | Ranbaxy |
Reviews
There are no reviews yet.